Drawing for TRIAL DIAL

USPTO serial 87789455

TRIAL DIAL

Reviewed by CopyMark Law Group

Reg. 5711201Status 702Registered
Filing date
Status date
Registration date
Mar 26, 2019
Examiner
KEAM, ALEX S
Law office
FILE DESTROYED

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with TRIAL DIAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jordan A LaVine

Jordan A LaVine FLASTER GREENBERG P.C.Suite 100, 100 Front StreetConshohocken, PA 19428United States

Goods and services

ClassDescriptionStatusFirst use
042Cloud computing featuring software for use with managing, gathering, organizing, and sharing data, information and images in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medial research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; Consulting services for others in the field of design, planning, and implementation project management of clinical trials and medical research; Providing a website featuring educational information in the field of clinical research; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing temporary use of on-line non-downloadable cloud computing software for managing, gathering, organizing, and sharing data, information and images in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medial research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; Software as a service (SAAS) services featuring software for managing, gathering, organizing, and sharing data, information and images in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medial research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply managementACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 26, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 26, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 26, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 9, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Mar 26, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 26, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 21, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 20, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 5, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 4, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 9, 2019IUAFUSE AMENDMENT FILED—
Jan 9, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 14, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 19, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 19, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 30, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 13, 2018ALIEASSIGNED TO LIE—
May 3, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 3, 2018XAECEXAMINER'S AMENDMENT ENTERED—
May 3, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 3, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
May 3, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
May 2, 2018DOCKASSIGNED TO EXAMINER—
Feb 16, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 12, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance